<DOC>
	<DOCNO>NCT02980263</DOCNO>
	<brief_summary>The purpose trial evaluate whether , Intravenous Immunoglobulin-naïve refractory patient diagnose active Kawasaki disease , administration canakinumab control fever acute phase reactant .</brief_summary>
	<brief_title>Study Efficacy Safety Canakinumab Pediatric Patients With Kawasaki Disease</brief_title>
	<detailed_description />
	<mesh_term>Mucocutaneous Lymph Node Syndrome</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Key Active Kawasaki disease define : fever ≥38.5°C ≥5 day four five follow criterion : ( ) conjunctival injection , ( ii ) oral mucous membrane change , ( e.g. , injected pharynx , strawberry tongue ) , ( iii ) erythema hand foot , ( iv ) polymorphous rash , ( v ) cervical lymphadenopathy Key Patients fulfil follow criterion eligible inclusion study : Previous Kawasaki Disease diagnosis , refractory and/or incomplete Kawasaki disease ( IVIGnaïve patient , Cohort 1 ) Patients fever long week ( Intravenous Immunoglobulinnaïve patient , Cohort 1 ) , longer 14 day ( Intravenous Immunoglobulinrefractory patient , Cohort 2 ) History hypersensitivity study drug drug similar chemical class excipients ( e.g . citric acid anhydrous sodium chloride disodium edetate dehydrate polysorbate 80 ; sodium hydroxide ; water injection ) Other protocoldefined inclusion/exclusion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Kawasaki disease</keyword>
	<keyword>Coronary artery aneurysm</keyword>
	<keyword>mucocutaneous lymph node syndrome</keyword>
	<keyword>lymph node syndrome</keyword>
	<keyword>canakinumab</keyword>
	<keyword>intravenous immunoglobulin naïve ( IVIG-naïve )</keyword>
	<keyword>intravenous immunoglobulin refractory ( IVIG-refractory )</keyword>
	<keyword>pediatric</keyword>
</DOC>